SlideShare a Scribd company logo
1 of 25
Neuromodulation technology
to end prolonged severe pain
© 2019 Valencell, Inc
Richard Hanbury
CEO
Sana Health
Our mission is deliver FREEDOM
from pain, and FREEDOM from
the anxiety that pain creates.
100 millionAMERICANS CURRENTLY
SUFFER FROM SEVERE PAIN
Today, opioids are still the gold
standard.
There were
72,000+ opioid
deaths in 2017.
addictions start with
prescription opioids
4 in 5
Opioids just mask pain
Rest &
Recovery
Fight or
Flight
Rest &
Recovery
Fight or
Flight
Severe Pain After Opioids
5
In 1992, the jeep I was
driving rolled off a bridge
and I was pronounced
dead.
The nerve damage was so
bad I was given 5 years to live.
In my search for pain relief I tried
everything first opioids, then
devices.
7
Magnetic
Electronic
Audio-
Visual
Nothing worked
until I discovered
the research on
brainwave
entrainment
(BWE).
Magneti
c
In 1993, I started
experimenting with
thousands of audio-visual
stimulation patterns.
I wiped out my pain and saved my
life.
Since then I have been pain-free.
Measures
individual
biometrics via HRV
Patterns change
based on FlowState
algorithm
Neurowave stimulation is activated
via light in front of the eyelids
and sound via headphones
A unique mask that uses
pulsed light and sound to
guide users
into a deep state of relaxation.
increases
relaxation
Induces Sleep
in 10-min
Reduces
pain
EEG of traumatic brain
patient with severe
pain
EEG after using
Sana Relief for 4
hours
The Sana device restores hemispheric
balance in the brain.
30
29
28
27
26
25
24
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
30
29
28
27
26
25
24
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Back to homeostasis.
Rest &
Recovery
Fight or
Flight
Rest &
Recovery
Fight or
Flight
Before Sana After Sana
Then induces deep drug-free
relaxation and strong pain relief.
Patent 1
Filed 2015
Patent 2
Filed 2016 Patent 3,4 &5
Filed
2018/19
13
We’ve secured strong and broad IP
We’ve piloted studies
with collaborators to
validate efficacy.
Completed Studies
14 14
Hattie, age 13
Severe Regional Pain Syndrome
"I cut my opioids in half, and
could touch my arm without
pain for the first time in 3
years. And in one week went
back to school."
50%
opioid reduction*
Achieved early
success in the most
severe cases.
*Based on four hours daily usage for first week and one hour ongoing daily
maintenance
We completed a 75-person sham-controlled
study with Stanford and SOCOM.
in relaxation
2x increase
in recovery and sleep*
5x improvement
in pain levels
3x reduction
united states Special
Operations Command
*Measures using heart rate
variability
• Double Blind randomized controlled trial, conducted by Dr. Lynn Webster at the PRA Salt Lake
inpatient clinic.
• 8 patient cross-over study (16 patient experiences) methadone addicts going into withdrawal
• Subjects had their usual methadone dose (60-80mg/day) withdrawn, and the trial was run to
compare their withdrawal symptoms on an active Sana device, versus a sham.
• The Sana device cut subjects’ Subjective Opioid Withdrawal Symptoms (SOWS) by ~30%
compared to sham. Clinical Opioid withdrawal symptoms (COWS) were also markedly reduced at
7 out of 10 time points.
• The Sana device demonstrated a dramatic effect on reducing nicotine cravings. One multi-decade
smoker reported he’d never smoke again, after one device use. This further validates that the
device reduces cravings and addictions.
• The Sana device proved superior to placebo on all other measures studied. These included
statistical significance in Anxiety, Pain, NEED for Methadone (craving), and Desire for Methadone.
Key Findings
External Clinical trial -Opioid Use Disorder.
*The Subjective Opiate Withdrawal Scale (SOWS) is a self-administered scale for grading opioid withdrawal symptoms
created
0
1
2
3
4
5
6
7
8
9
Baseline (AM) Treatment (AM) Treatment (PM)
SOWSScores
Active Sham
Active lower at all time points.
Subjective Opioid Withdrawal Symptoms* mean scores By Period
Clinical Opioid Withdrawal Symptoms* mean scores across subjects
*The Clinical Opiate Withdrawal Score (COWS) score quantifies severity of opiate withdrawal and can be
serially administered to track changes in the severity of withdrawal symptoms over time or in response to
treatment
0
1.5
3
4.5
1 2 3 4 5 6 7 8 9 10
COWSMeanScores
Day 1 Scores by Period
Active Sham
Active lower at all time points except 2.
Mean reduction of other 8 timepoints 20%.
VAS-a Anxiety Scores*
*Measure of anxiety is an emotional state characterized by apprehension and fear resulting
from anticipation of a threatening event using a Visual Analogue Scale for Anxiety (VAS-A)
0
5
10
15
20
25
30
1 2 3 4 5 6 7 8 9 10
VAS-AScores
Day 1 Scores by Period
Active Sham
Anxiety scores across study period – active lowered anxiety by 36% P=.047
Rising to 45% on average at end of study period P=.043 when withdrawal symptoms were
most severe.
*The pain VAS is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations
0
8
16
24
VAS-PScores
Day 1 Scores Combined Across All Observations
Active Sham
Pain scores, showing a 39% drop on active v sham.
For those who were treated Actively in the first
session, controlling for Sequence; P=.001
VAS-p Pain Scores*Across Subjects
VAS-n NEED Scores*
*The need VAS is a unidimensional measure of the feeling of need, which has been widely used in buprenorphine trials
0
5
10
15
20
25
1 2 3 4 5 6 7 8 9 10
VAS-NeedTotalScore
Day 1 Scores by Period
Active Sham
VAS Methadone NEED scores across day 1 study
period.
NEED reduced on average 39% in active group
P=.041.
Our clinical roadmap is clear.
Condition Trial Site Funded
Opioid Use
Disorder (Trial
Complete)
✓
Fibromyalgia ✓
Severe Pain ✗
Neuropathic
Pain ✓
Oncology Pain
CU Denver
Anschutz (TBC) ✗
FDA
FDA
FDA
FDA
Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020
FDA
CEO & Founder Chief Operating Officer Chief Commercial Officer Chief Financial Officer
Richard Hanbury Tasha Bond Steve SandersGeoff Birkett
Team Leadership
Inventor and developer
25 years with this
technology
20 years in med-tech
4 successful exits
Launched Nicorette
Led merger of Zeneca/Astra
10 years in med-tech
$2.5B in M&A experience
24
Neuromodulation
technology to end
prolonged severe pain.
Richard Hanbury CEO
richard@sana.io
+1 415 630 0467

More Related Content

Similar to Applying heart rate data to optimize pain relief: A conversation with Sana Health

2011 passey treatment chronic pain
2011 passey treatment chronic pain2011 passey treatment chronic pain
2011 passey treatment chronic pain
workcomp
 
ORIGINAL ARTICLE HIP - ANESTHESIAA randomized controlled.docx
ORIGINAL ARTICLE  HIP - ANESTHESIAA randomized controlled.docxORIGINAL ARTICLE  HIP - ANESTHESIAA randomized controlled.docx
ORIGINAL ARTICLE HIP - ANESTHESIAA randomized controlled.docx
gerardkortney
 
The Nurse Practitioner Role in Increasing Access to Pain Care
The Nurse Practitioner Role in Increasing Access to Pain CareThe Nurse Practitioner Role in Increasing Access to Pain Care
The Nurse Practitioner Role in Increasing Access to Pain Care
npeducation
 
Pain management overview 2013
Pain management overview 2013Pain management overview 2013
Pain management overview 2013
derosaMSKCC
 

Similar to Applying heart rate data to optimize pain relief: A conversation with Sana Health (20)

2015: Pain Assessment, the Key to Treating Pain in the Inpatient Setting-Yi
2015: Pain Assessment, the Key to Treating Pain in the Inpatient Setting-Yi2015: Pain Assessment, the Key to Treating Pain in the Inpatient Setting-Yi
2015: Pain Assessment, the Key to Treating Pain in the Inpatient Setting-Yi
 
2011 passey treatment chronic pain
2011 passey treatment chronic pain2011 passey treatment chronic pain
2011 passey treatment chronic pain
 
An overview of drug regulatory system in South Africa
An overview of drug regulatory system in South AfricaAn overview of drug regulatory system in South Africa
An overview of drug regulatory system in South Africa
 
National Summit On Opioid Safety
National Summit On Opioid  SafetyNational Summit On Opioid  Safety
National Summit On Opioid Safety
 
Clinical effect and safety of pulsed radiofrequency treatment for pudendal ne...
Clinical effect and safety of pulsed radiofrequency treatment for pudendal ne...Clinical effect and safety of pulsed radiofrequency treatment for pudendal ne...
Clinical effect and safety of pulsed radiofrequency treatment for pudendal ne...
 
Optimising pain management by esther munyoro
Optimising pain management by esther munyoroOptimising pain management by esther munyoro
Optimising pain management by esther munyoro
 
Optimising pain management by esther munyoro
Optimising pain management by esther munyoroOptimising pain management by esther munyoro
Optimising pain management by esther munyoro
 
ORIGINAL ARTICLE HIP - ANESTHESIAA randomized controlled.docx
ORIGINAL ARTICLE  HIP - ANESTHESIAA randomized controlled.docxORIGINAL ARTICLE  HIP - ANESTHESIAA randomized controlled.docx
ORIGINAL ARTICLE HIP - ANESTHESIAA randomized controlled.docx
 
Pediatric pain management
Pediatric pain managementPediatric pain management
Pediatric pain management
 
High Alert Medication
 High Alert Medication  High Alert Medication
High Alert Medication
 
High Alert Medication
 High Alert Medication  High Alert Medication
High Alert Medication
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Ems world expo pain management 11112014.handout
Ems world expo pain management 11112014.handoutEms world expo pain management 11112014.handout
Ems world expo pain management 11112014.handout
 
M christensen pain+management
M christensen pain+managementM christensen pain+management
M christensen pain+management
 
Responsible Opioid Prescribing for CNP
Responsible Opioid Prescribing for CNPResponsible Opioid Prescribing for CNP
Responsible Opioid Prescribing for CNP
 
The Nurse Practitioner Role in Increasing Access to Pain Care
The Nurse Practitioner Role in Increasing Access to Pain CareThe Nurse Practitioner Role in Increasing Access to Pain Care
The Nurse Practitioner Role in Increasing Access to Pain Care
 
10461913 2.ppt
10461913 2.ppt10461913 2.ppt
10461913 2.ppt
 
dr-170826095415.pptx
dr-170826095415.pptxdr-170826095415.pptx
dr-170826095415.pptx
 
Pedoman penatalaksanaan nyeri kanker.
Pedoman penatalaksanaan nyeri kanker.Pedoman penatalaksanaan nyeri kanker.
Pedoman penatalaksanaan nyeri kanker.
 
Pain management overview 2013
Pain management overview 2013Pain management overview 2013
Pain management overview 2013
 

More from Valencell, Inc

More from Valencell, Inc (20)

Hypertension management will change more in the next 5 years than in the last...
Hypertension management will change more in the next 5 years than in the last...Hypertension management will change more in the next 5 years than in the last...
Hypertension management will change more in the next 5 years than in the last...
 
Blood pressure market research study - November 2020
Blood pressure market research study - November 2020Blood pressure market research study - November 2020
Blood pressure market research study - November 2020
 
Best practices in using wearable biometric sensors to prove medical use cases
Best practices in using wearable biometric sensors to prove medical use casesBest practices in using wearable biometric sensors to prove medical use cases
Best practices in using wearable biometric sensors to prove medical use cases
 
Using biometric wearables in neuroscience & human behavior
Using biometric wearables in neuroscience & human behaviorUsing biometric wearables in neuroscience & human behavior
Using biometric wearables in neuroscience & human behavior
 
Advanced heart rate training for at-home training
Advanced heart rate training for at-home trainingAdvanced heart rate training for at-home training
Advanced heart rate training for at-home training
 
Webinar: Calibration-free blood pressure monitoring using biometric earbuds
Webinar: Calibration-free blood pressure monitoring using biometric earbudsWebinar: Calibration-free blood pressure monitoring using biometric earbuds
Webinar: Calibration-free blood pressure monitoring using biometric earbuds
 
Utilizing wearable technology in remote patient monitoring with aging populat...
Utilizing wearable technology in remote patient monitoring with aging populat...Utilizing wearable technology in remote patient monitoring with aging populat...
Utilizing wearable technology in remote patient monitoring with aging populat...
 
Hearing loss and the associated comorbidities: A conversation with Sonova
Hearing loss and the associated comorbidities: A conversation with SonovaHearing loss and the associated comorbidities: A conversation with Sonova
Hearing loss and the associated comorbidities: A conversation with Sonova
 
Why Data Science Matters and How It Enables Impactful Health Outcomes - Webinar
Why Data Science Matters and How It Enables Impactful Health Outcomes - WebinarWhy Data Science Matters and How It Enables Impactful Health Outcomes - Webinar
Why Data Science Matters and How It Enables Impactful Health Outcomes - Webinar
 
Wearable technology and blood pressure monitoring: Addressing the global hype...
Wearable technology and blood pressure monitoring: Addressing the global hype...Wearable technology and blood pressure monitoring: Addressing the global hype...
Wearable technology and blood pressure monitoring: Addressing the global hype...
 
Utilizing heart rate data to improve swimmers’ performance: A conversation wi...
Utilizing heart rate data to improve swimmers’ performance: A conversation wi...Utilizing heart rate data to improve swimmers’ performance: A conversation wi...
Utilizing heart rate data to improve swimmers’ performance: A conversation wi...
 
The Evolution of Hearables
The Evolution of HearablesThe Evolution of Hearables
The Evolution of Hearables
 
What are biometric parameters and why do they matter?
What are biometric parameters and why do they matter? What are biometric parameters and why do they matter?
What are biometric parameters and why do they matter?
 
Artificial intelligence-powered wearable solutions for senior care: A convers...
Artificial intelligence-powered wearable solutions for senior care: A convers...Artificial intelligence-powered wearable solutions for senior care: A convers...
Artificial intelligence-powered wearable solutions for senior care: A convers...
 
Wearables in Clinical Trials: Opportunities and Challenges
Wearables in Clinical Trials: Opportunities and ChallengesWearables in Clinical Trials: Opportunities and Challenges
Wearables in Clinical Trials: Opportunities and Challenges
 
Top Wearables Predictions for the Year Ahead and 2018: Year in Review
Top Wearables Predictions for the Year Ahead and 2018: Year in ReviewTop Wearables Predictions for the Year Ahead and 2018: Year in Review
Top Wearables Predictions for the Year Ahead and 2018: Year in Review
 
State of Wearables Today - 2018 Consumer Survey
State of Wearables Today - 2018 Consumer SurveyState of Wearables Today - 2018 Consumer Survey
State of Wearables Today - 2018 Consumer Survey
 
Expanding hearables and next generation hearing health: A conversation with S...
Expanding hearables and next generation hearing health: A conversation with S...Expanding hearables and next generation hearing health: A conversation with S...
Expanding hearables and next generation hearing health: A conversation with S...
 
Solving Children’s Enuresis with an AI Biometric Wearable Solution
Solving Children’s Enuresis with an AI Biometric Wearable SolutionSolving Children’s Enuresis with an AI Biometric Wearable Solution
Solving Children’s Enuresis with an AI Biometric Wearable Solution
 
SVHealth2.0 Wearables Symposium - August 2018
SVHealth2.0 Wearables Symposium - August 2018SVHealth2.0 Wearables Symposium - August 2018
SVHealth2.0 Wearables Symposium - August 2018
 

Recently uploaded

Recently uploaded (20)

🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, AdobeApidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
Apidays New York 2024 - Scaling API-first by Ian Reasor and Radu Cotescu, Adobe
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live StreamsTop 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
 
Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024Tata AIG General Insurance Company - Insurer Innovation Award 2024
Tata AIG General Insurance Company - Insurer Innovation Award 2024
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)
 
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
Top 10 Most Downloaded Games on Play Store in 2024
Top 10 Most Downloaded Games on Play Store in 2024Top 10 Most Downloaded Games on Play Store in 2024
Top 10 Most Downloaded Games on Play Store in 2024
 
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
Bajaj Allianz Life Insurance Company - Insurer Innovation Award 2024
 

Applying heart rate data to optimize pain relief: A conversation with Sana Health

  • 1. Neuromodulation technology to end prolonged severe pain © 2019 Valencell, Inc Richard Hanbury CEO Sana Health
  • 2. Our mission is deliver FREEDOM from pain, and FREEDOM from the anxiety that pain creates.
  • 3. 100 millionAMERICANS CURRENTLY SUFFER FROM SEVERE PAIN Today, opioids are still the gold standard.
  • 4. There were 72,000+ opioid deaths in 2017. addictions start with prescription opioids 4 in 5
  • 5. Opioids just mask pain Rest & Recovery Fight or Flight Rest & Recovery Fight or Flight Severe Pain After Opioids 5
  • 6. In 1992, the jeep I was driving rolled off a bridge and I was pronounced dead. The nerve damage was so bad I was given 5 years to live.
  • 7. In my search for pain relief I tried everything first opioids, then devices. 7
  • 8. Magnetic Electronic Audio- Visual Nothing worked until I discovered the research on brainwave entrainment (BWE).
  • 9. Magneti c In 1993, I started experimenting with thousands of audio-visual stimulation patterns. I wiped out my pain and saved my life. Since then I have been pain-free.
  • 10. Measures individual biometrics via HRV Patterns change based on FlowState algorithm Neurowave stimulation is activated via light in front of the eyelids and sound via headphones A unique mask that uses pulsed light and sound to guide users into a deep state of relaxation. increases relaxation Induces Sleep in 10-min Reduces pain
  • 11. EEG of traumatic brain patient with severe pain EEG after using Sana Relief for 4 hours The Sana device restores hemispheric balance in the brain. 30 29 28 27 26 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 30 29 28 27 26 25 24 23 22 21 20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 Back to homeostasis.
  • 12. Rest & Recovery Fight or Flight Rest & Recovery Fight or Flight Before Sana After Sana Then induces deep drug-free relaxation and strong pain relief.
  • 13. Patent 1 Filed 2015 Patent 2 Filed 2016 Patent 3,4 &5 Filed 2018/19 13 We’ve secured strong and broad IP
  • 14. We’ve piloted studies with collaborators to validate efficacy. Completed Studies 14 14
  • 15. Hattie, age 13 Severe Regional Pain Syndrome "I cut my opioids in half, and could touch my arm without pain for the first time in 3 years. And in one week went back to school." 50% opioid reduction* Achieved early success in the most severe cases. *Based on four hours daily usage for first week and one hour ongoing daily maintenance
  • 16. We completed a 75-person sham-controlled study with Stanford and SOCOM. in relaxation 2x increase in recovery and sleep* 5x improvement in pain levels 3x reduction united states Special Operations Command *Measures using heart rate variability
  • 17. • Double Blind randomized controlled trial, conducted by Dr. Lynn Webster at the PRA Salt Lake inpatient clinic. • 8 patient cross-over study (16 patient experiences) methadone addicts going into withdrawal • Subjects had their usual methadone dose (60-80mg/day) withdrawn, and the trial was run to compare their withdrawal symptoms on an active Sana device, versus a sham. • The Sana device cut subjects’ Subjective Opioid Withdrawal Symptoms (SOWS) by ~30% compared to sham. Clinical Opioid withdrawal symptoms (COWS) were also markedly reduced at 7 out of 10 time points. • The Sana device demonstrated a dramatic effect on reducing nicotine cravings. One multi-decade smoker reported he’d never smoke again, after one device use. This further validates that the device reduces cravings and addictions. • The Sana device proved superior to placebo on all other measures studied. These included statistical significance in Anxiety, Pain, NEED for Methadone (craving), and Desire for Methadone. Key Findings External Clinical trial -Opioid Use Disorder.
  • 18. *The Subjective Opiate Withdrawal Scale (SOWS) is a self-administered scale for grading opioid withdrawal symptoms created 0 1 2 3 4 5 6 7 8 9 Baseline (AM) Treatment (AM) Treatment (PM) SOWSScores Active Sham Active lower at all time points. Subjective Opioid Withdrawal Symptoms* mean scores By Period
  • 19. Clinical Opioid Withdrawal Symptoms* mean scores across subjects *The Clinical Opiate Withdrawal Score (COWS) score quantifies severity of opiate withdrawal and can be serially administered to track changes in the severity of withdrawal symptoms over time or in response to treatment 0 1.5 3 4.5 1 2 3 4 5 6 7 8 9 10 COWSMeanScores Day 1 Scores by Period Active Sham Active lower at all time points except 2. Mean reduction of other 8 timepoints 20%.
  • 20. VAS-a Anxiety Scores* *Measure of anxiety is an emotional state characterized by apprehension and fear resulting from anticipation of a threatening event using a Visual Analogue Scale for Anxiety (VAS-A) 0 5 10 15 20 25 30 1 2 3 4 5 6 7 8 9 10 VAS-AScores Day 1 Scores by Period Active Sham Anxiety scores across study period – active lowered anxiety by 36% P=.047 Rising to 45% on average at end of study period P=.043 when withdrawal symptoms were most severe.
  • 21. *The pain VAS is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations 0 8 16 24 VAS-PScores Day 1 Scores Combined Across All Observations Active Sham Pain scores, showing a 39% drop on active v sham. For those who were treated Actively in the first session, controlling for Sequence; P=.001 VAS-p Pain Scores*Across Subjects
  • 22. VAS-n NEED Scores* *The need VAS is a unidimensional measure of the feeling of need, which has been widely used in buprenorphine trials 0 5 10 15 20 25 1 2 3 4 5 6 7 8 9 10 VAS-NeedTotalScore Day 1 Scores by Period Active Sham VAS Methadone NEED scores across day 1 study period. NEED reduced on average 39% in active group P=.041.
  • 23. Our clinical roadmap is clear. Condition Trial Site Funded Opioid Use Disorder (Trial Complete) ✓ Fibromyalgia ✓ Severe Pain ✗ Neuropathic Pain ✓ Oncology Pain CU Denver Anschutz (TBC) ✗ FDA FDA FDA FDA Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 FDA
  • 24. CEO & Founder Chief Operating Officer Chief Commercial Officer Chief Financial Officer Richard Hanbury Tasha Bond Steve SandersGeoff Birkett Team Leadership Inventor and developer 25 years with this technology 20 years in med-tech 4 successful exits Launched Nicorette Led merger of Zeneca/Astra 10 years in med-tech $2.5B in M&A experience 24
  • 25. Neuromodulation technology to end prolonged severe pain. Richard Hanbury CEO richard@sana.io +1 415 630 0467

Editor's Notes

  1. Need context. Opioids now kill more people than breast cancer. That’s 174 people per day. In the United States.
  2. A Japanese television station broadcast a light and sound ‘strobe effect’ as part of a cartoon in 1997. In only 5 seconds, it put 700 children into hospital with seizures, and untold thousands more experienced headaches, dizziness, and nausea. https://www.nytimes.com/1997/12/18/world/tv-cartoon-s-flashes-send-700-japanese-into-seizures.html
  3. While I was in the hospital, my pain was so severe I couldn’t sleep. If we were conversing, I couldn’t concentrate on what you were saying. I was watching Hudson Hawk, one of Bruce Willis early movies, and I was so transfixed that I forgot about my pain. This is me in 1993 when I started recording a QEEG brain map. I could see that my brain was on high alert; the areas involved in pain reactivity and heart rate were running at triple the comfortable rate (I don’t know the actual rates). No wonder I was uncomfortable. After careful analysis of my brain activity, I found that the underlying pain was affecting my ability to shift from an alert state to rest; the likely culprit on my severe pain and sleep troubles. The pain and anxiety were taking the majority of my brain’s resources, and there is little left for concentration, clear decision making let alone restful sleep and recovery. Having identified the areas of concern, I created a neuro-feedback training plan and experimented with thousands of patterns. Hudson Hawk was the movie that put me in the flow state, so used that as the feedback for my training sessions. During my neuro-feedback sessions, I monitored the areas involved in my pain and heart rate in real-time. When my brain would move towards a calmer position, I would change the sound patterns– positive signal letting my mind know I am heading the right way. When I was getting a bit more internally anxious, the lights would go darker, and the sound faded – a negative signal telling my brain that we were heading the wrong way. I did this until I could continually shift further and further into a more and more balanced, non-anxious state. As I did this time and again, my brain was trained on how to return my mind to a calm position instantly. As I tracked my progress, I noticed a corresponding shift on my brain map. It took me 6 months to finally realize that the pain was never coming back. Since 1993 I’ve been pain-free. This is why I founded Sana and why we’re going to end severe pain forever.
  4. Send Away Sana uses closed-loop-feedback and biosensors to personalize treatment based on physiologic systems.
  5. Here is the EEG of an early patient with traumatic brain injury and severe pain. In the before graph you can see his EEG before using Sana, note the large hemispheric imbalance. In the after graph you can see his EEG after using Sana, his hemispheric balance has been restored, he was more relaxed and his pain levels were lower.
  6. Send Away Version Introducing Hattie Hattie has this issues. One day she found Sana. She uses Sana for maintenance. Now she uses Sana for Pain MGMT instead of opioids.